MetLife Investment Management, LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1529735
Whippany, NJ
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,792,263
-$3,011,067 QoQ
Shares Held
71,062
-49.4% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#123
of 499 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. ARWR ranks #12 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,792,263 | 71,062 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,803,330 | 140,404 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,849,125 | 73,040 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,482,003 | 71,963 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,137,015 | 71,963 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $916,808 | 71,963 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,651,006 | 141,011 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,538,031 | 131,029 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,434,084 | 132,131 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,600,225 | 125,882 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,452,383 | 112,823 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $3,057,026 | 113,771 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $4,151,251 | 116,412 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $3,004,718 | 118,296 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $4,809,564 | 118,579 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $3,963,488 | 119,924 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $4,248,297 | 120,656 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $5,528,779 | 120,217 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $5,657,113 | 85,326 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $5,374,348 | 86,086 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $7,288,822 | 88,008 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $6,060,800 | 91,401 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $7,382,116 | 96,209 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $4,333,601 | 100,641 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $4,518,624 | 104,622 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $2,875,101 | 99,934 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||